OTCMKTS:BFNH BioForce Nanosciences (BFNH) Stock Price, News & Analysis $1.65 0.00 (0.00%) As of 06/26/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About BioForce Nanosciences Stock (OTCMKTS:BFNH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioForce Nanosciences alerts:Sign Up Key Stats Today's Range$1.65▼$1.6550-Day Range$0.35▼$1.7952-Week Range$0.18▼$1.90Volume51 shsAverage Volume10,619 shsMarket Capitalization$55.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioForce Nanosciences, Inc. develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale. The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning. In addition to equipment sales, BioForce Nanosciences offers contract research and custom development services, as well as licensing agreements for its intellectual property. Its technologies have been applied in areas such as drug delivery, tissue engineering, advanced filtration, composite materials and sensor development. Serving academic institutions, government laboratories and corporate research centers, BioForce Nanosciences supports customers worldwide with training, application development and technical service. By combining instrumentation, service offerings and technology licensing, the company aims to accelerate the translation of nanomaterial innovations into practical solutions for life science, industrial and environmental applications.AI Generated. May Contain Errors. Read More Receive BFNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BFNH Stock News HeadlinesBioForce Nanosciences (OTCMKTS:BFNH) Stock Price Down 7.8% - Time to Sell?June 23, 2026 | americanbankingnews.comBioForce Nanosciences Delays Annual 10-K FilingApril 10, 2026 | theglobeandmail.comThe startup growing 23 times faster than NvidiaAn official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes could be the next monster IPO on Wall Street. This company is growing 23 times faster than Nvidia. The Atlantic called it 'the fastest-growing business in the history of capitalism.' It has nothing to do with robots, self-driving cars, or rockets.June 30 at 1:00 AM | Brownstone Research (Ad)BFNH BioForce Nanosciences Holdings, Inc. - Seeking AlphaJuly 31, 2025 | seekingalpha.comBuilding a DNA nanoparticle to be both carrier and medicineFebruary 6, 2024 | msn.comBiomedical Applications Of Nanoscale Devices Market Report Include Detail about Competitor Analysis 2023-2030April 22, 2023 | marketwatch.comBioForce Nanosciences Holdings, Inc. (BFNH)August 20, 2022 | ca.finance.yahoo.comBioForce Nanosciences Holdings Inc (BFNH)January 23, 2022 | nasdaq.comSee More Headlines BFNH Stock Analysis - Frequently Asked Questions How have BFNH shares performed this year? BioForce Nanosciences' stock was trading at $0.5780 at the beginning of the year. Since then, BFNH stock has increased by 185.5% and is now trading at $1.65. How were BioForce Nanosciences' earnings last quarter? BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.03) earnings per share for the quarter. How do I buy shares of BioForce Nanosciences? Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioForce Nanosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioForce Nanosciences investors own include Charlotte's Web (CWBHF). Company Calendar Last Earnings5/13/2025Today6/30/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMeasuring And Control Equipment Current SymbolOTCMKTS:BFNH CIK1310488 Webwww.bioforceeclipse.com Phone(757) 306-6090Fax757-306-6092Employees2Year Founded2003Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.29 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-20,856.95% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-82.50Miscellaneous Outstanding Shares33,550,000Free Float20,284,000Market Cap$55.36 million OptionableNot Optionable Beta-0.31 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:BFNH) was last updated on 6/30/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThe startup growing 23 times faster than NvidiaAn official SEC document contains a name Elon Musk revealed on page 146 - a startup that one analyst believes ...Brownstone Research | SponsoredGold Is About to Do Something It Hasn’t in 90 YearsThe U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...US Gold Bureau | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioForce Nanosciences Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioForce Nanosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.